These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3530124)

  • 1. Susceptibility of Eikenella corrodens to newer and older quinolones.
    Goldstein EJ; Citron DM; Vagvolgyi AE; Gombert ME
    Antimicrob Agents Chemother; 1986 Jul; 30(1):172-3. PubMed ID: 3530124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1984 Dec; 26(6):947-8. PubMed ID: 6395802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Eikenella corrodens to ten cephalosporins.
    Goldstein EJ; Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1978 Oct; 14(4):639-41. PubMed ID: 363054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Eikenella corrodens to antimicrobial agents.
    Sofianou D; Kolokotronis A
    J Chemother; 1990 Jun; 2(3):156-8. PubMed ID: 2199625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens.
    Goldstein EJ; Cherubin CE; Shulman M
    Antimicrob Agents Chemother; 1983 Jan; 23(1):42-5. PubMed ID: 6338819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics.
    Goldstein EJ; Gombert ME; Agyare EO
    Antimicrob Agents Chemother; 1980 Nov; 18(5):832-3. PubMed ID: 7004350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Bacteroides corrodens and Eikenella corrodens to ten chemotherapeutic agents.
    Robinson JV; James AL
    Antimicrob Agents Chemother; 1974 Nov; 6(5):543-6. PubMed ID: 15825302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents.
    Goldstein EJ; Cherubin CE; Corrado ML; Sierra MF
    Rev Infect Dis; 1982; 4 Suppl():S406-10. PubMed ID: 6294791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):856-9. PubMed ID: 1323956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atmosphere of incubation and inoculum size on the susceptibility of Eikenella corrodens.
    Goldstein EJ; Gombert ME; Agyare EO
    J Antimicrob Chemother; 1982 Jul; 10(1):37-42. PubMed ID: 6809725
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro susceptibility of Eikenella corrodens to thirteen beta-lactam antibiotics and fosfomycin.
    Schröter G; Strobel I
    Eur J Clin Microbiol; 1983 Dec; 2(6):608-9. PubMed ID: 6365541
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of 14 antimicrobials against Eikenella corrodens].
    Vay C; Almuzara M; Barberis C; Rodriguez C; Togneri A; Mattera J; Famiglietti A
    Rev Argent Microbiol; 2002; 34(4):230-4. PubMed ID: 12600009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of broth microdilution method using Haemophilus test medium and agar dilution method for susceptibility testing of Eikenella corrodens.
    Alcalá L; García-Garrote F; Cercenado E; Peláez T; Ramos G; Bouza E
    J Clin Microbiol; 1998 Aug; 36(8):2386-8. PubMed ID: 9666033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
    Smith SM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez H
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1141-3. PubMed ID: 11897609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
    Knapp JS; Hale JA; Neal SW; Wintersheid K; Rice RJ; Whittington WL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2442-5. PubMed ID: 8585723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
    Fenlon CH; Cynamon MH
    Antimicrob Agents Chemother; 1986 Mar; 29(3):386-8. PubMed ID: 2940969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.